Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye

ClinicalTrials.gov ID: NCT02965846

Public ClinicalTrials.gov record NCT02965846. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02965846
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allergan
Industry
Enrollment
43 participants

Conditions and interventions

Interventions

  • AGN-195263 Drug
  • Vehicle Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 12, 2016
Primary completion
Jun 12, 2017
Completion
Jun 12, 2017
Last update posted
Nov 29, 2018

2016 – 2017

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Sall Research Medical Center Artesia California 90701
Lugene Eye Institute Glendale California 91204
Lifelong Vision Foundation Chesterfield Missouri 63017
Devers Eye Institute Portland Oregon 97210
Scott and Christie Associates Cranberry Township Pennsylvania 16066
Wills Eye Hospital Philadelphia Pennsylvania 19107
Medical Center Ophthalmology Associates San Antonio Texas 78240
Piedmont Eye Center Lynchburg Virginia 24502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02965846, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 29, 2018 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02965846 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →